Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage

  • Read more about Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage
Patent Cooperation Treaty
PCT/US2016/032192
Filed on 2016-05-12

COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT

  • Read more about COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT
US Patent 10,464,970
Filed on 2016-04-21

Hypoxia Inducible Factor 1 (HIF-1) Inhibitors

  • Read more about Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
Patent Cooperation Treaty
PCT/US2016/026145
Filed on 2016-04-06

Ratio Based Biomarkers And Methods of Use Thereof

  • Read more about Ratio Based Biomarkers And Methods of Use Thereof
Australia
2016202107
Filed on 2016-04-05

Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof

  • Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof
Hong Kong
16108042.3
Filed on 2012-04-19

Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use

  • Read more about Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use
US Patent 10,143,724
Filed on 2016-04-19

Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood

  • Read more about Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood
Patent Cooperation Treaty
PCT/US16/030137
Filed on 2016-04-29

Modified Pseudomonas Exotoxin A

  • Read more about Modified Pseudomonas Exotoxin A
Japan
2016-520651
Filed on 2016-04-06

Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same

  • Read more about Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same
Japan
2016-536812
Filed on 2014-10-30

ALK Antibodies, Conjugates, and Chimeric Antigen Receptors, and Their Use

  • Read more about ALK Antibodies, Conjugates, and Chimeric Antigen Receptors, and Their Use
US Application 15/034,171
Filed on 2016-05-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 607
  • Page 608
  • Page 609
  • Page 610
  • Page 611
  • Page 612
  • Page 613
  • Page 614
  • Page 615
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health